116 related articles for article (PubMed ID: 3549964)
41. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
Meenakshi A; Kumar NS; Vijayshanker SG
Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
[TBL] [Abstract][Full Text] [Related]
42. [Interference in double-determinant monoclonal antibody-based assay for carcinoembryonic antigen (CEA)].
Sekiguchi H; Otake T; Kano S; Iri H
Rinsho Byori; 1989 Aug; 37(8):893-8. PubMed ID: 2685406
[TBL] [Abstract][Full Text] [Related]
43. Limited improvement of tumour diagnosis by the simultaneous determination of carcinoembryonic antigen (CEA) and of a tumour-associated CEA-related antigen of Mr 128,000 in serum.
Wagener C; Wickert L; Meyers W
J Clin Chem Clin Biochem; 1989 Sep; 27(9):643-52. PubMed ID: 2691631
[TBL] [Abstract][Full Text] [Related]
44. [Carcinoembryonic antigen in serum and tissue of benign and cancerous breast lesions].
von Kleist S; Wittekind C; Polack M; Gropp H; Sandritter W
Arch Geschwulstforsch; 1981; 51(6):523-6. PubMed ID: 6277268
[TBL] [Abstract][Full Text] [Related]
45. Immunoradiometric assay of carcinoembryonic antigen with use of avidin-biotin labeling.
Peters J; Schmidt-Gayk H; Peters B; Armbruster FP; Quentmeier A; Mathias D
Clin Chem; 1989 Apr; 35(4):573-6. PubMed ID: 2649275
[TBL] [Abstract][Full Text] [Related]
46. Antigenic heterogeneity of carcinoembryonic antigen in the circulation defined by monoclonal antibodies against the carbohydrate moiety of carcinoembryonic antigen and closely related antigens.
Matsunaga A; Kuroki M; Higuchi H; Arakawa F; Takakura K; Okamoto N; Matsuoka Y
Cancer Res; 1987 Jan; 47(1):56-61. PubMed ID: 2431767
[TBL] [Abstract][Full Text] [Related]
47. Major disagreements between immunoassays of carcinoembryonic antigen may be caused by nonspecific cross-reacting antigen 2 (NCA-2).
Börmer OP
Clin Chem; 1991 Oct; 37(10 Pt 1):1736-9. PubMed ID: 1914175
[TBL] [Abstract][Full Text] [Related]
48. Immunological characteristics of monoclonal antibodies against human carcinoembryonic antigen (CEA).
Tsai LC; Wang FM; Pan LC; Perng AC; Han SH
Proc Natl Sci Counc Repub China B; 1985 Oct; 9(4):287-97. PubMed ID: 2419936
[TBL] [Abstract][Full Text] [Related]
49. Tumor specificity of monoclonal antibodies to carcinoembryonic antigen. Immunohistochemical analysis.
Zoubir F; Zeromski J; Sikora J; Szmeja J; Hedin A; Hammarström S
Tumour Biol; 1990; 11(1-2):5-19. PubMed ID: 2408131
[TBL] [Abstract][Full Text] [Related]
50. Epitope group specificity of six immunoassays for carcinoembryonic antigen.
Börmer OP; Thrane-Steen K
Tumour Biol; 1991; 12(1):9-15. PubMed ID: 1705049
[TBL] [Abstract][Full Text] [Related]
51. Immunological comparison of ovarian and colonic CEA.
Burtin P; Lamerz R; Gendron MC; Maunoury MT; Schnabel G
Immunol Lett; 1982 Feb; 4(2):87-91. PubMed ID: 6174431
[TBL] [Abstract][Full Text] [Related]
52. Immunoperoxidase staining of carcinoembryonic antigen with monoclonal antibodies in adenocarcinoma of the colon.
Lindgren J; Wahlström T; Bång B; Hurme M; Mäkelä O
Histochemistry; 1982; 74(2):223-7. PubMed ID: 6757195
[TBL] [Abstract][Full Text] [Related]
53. [Clinical value of serum CEA measured by the McAb-enzyme immunoassay in cancer patients].
Xiao YK; Lin P; Lu YR; Cao JX; Huang XZ
Hua Xi Yi Ke Da Xue Xue Bao; 1987 Mar; 18(1):33-6. PubMed ID: 3305301
[No Abstract] [Full Text] [Related]
54. Noncompetitive enzyme immunoassay for carcinoembryonic antigen by flow injection chemiluminescence.
Lin J; Yan F; Ju H
Clin Chim Acta; 2004 Mar; 341(1-2):109-15. PubMed ID: 14967165
[TBL] [Abstract][Full Text] [Related]
55. [Clinical usefulness of carcinoembryonic antigen measurement in nipple discharge as an adjunctive tool for diagnosis of breast cancer].
Nishiguchi T; Hishimoto T; Funahashi S; Takatsuka Y; Kawahara T
Rinsho Byori; 1992 Jan; 40(1):67-72. PubMed ID: 1545528
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of a commercial enzyme radioimmunoassay kit for serum carcinoembryonic antigen.
Fabricatorian D; Gallagher ND
Ann Clin Biochem; 1981 Jul; 18(Pt 4):248-51. PubMed ID: 7025735
[TBL] [Abstract][Full Text] [Related]
57. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
Wu JT; Miya T; Knight JA; Knight DP
Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
[TBL] [Abstract][Full Text] [Related]
58. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer.
Albanopoulos K; Armakolas A; Konstadoulakis MM; Leandros E; Tsiompanou E; Katsaragakis S; Alexiou D; Androulakis G
Am J Gastroenterol; 2000 Apr; 95(4):1056-61. PubMed ID: 10763959
[TBL] [Abstract][Full Text] [Related]
60. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
